Skip to main content
. 2019 Nov 20;318(1):C163–C173. doi: 10.1152/ajpcell.00107.2019

Table 1.

Mobile fractions and exchange half-lives of titin-mEos3.2 hiPSC-CMs

Treatment Mobile Fraction % t1/2, h
Untreated control (n = 4) 68.1 ± 5.7 1.2 ± 0.19
DMSO (n = 4) 63.4 ± 5.0 1.3 ± 0.20
Cycloheximide (n = 3) 62.8 ± 5.2 2.1 ± 0.02*
Fixed (n = 3) 55.5 ± 5.3 3.3 ± 0.35*

Data are presented as means ± SE. hiPSCs-CMs, human induced pluripotent stem cell-cardiomyocytes.

*

P < 0.05 vs. control, groups compared by ANOVA.